SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-055598
Filing Date
2021-04-27
Accepted
2021-04-27 16:07:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212505d3_defa14a.htm DEFA14A 36364
2 GRAPHIC tm212505d3_defa14aimg001.jpg GRAPHIC 349123
3 GRAPHIC tm212505d3_defa14aimg002.jpg GRAPHIC 238444
  Complete submission text file 0001104659-21-055598.txt   846989
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33451 | Film No.: 21858971
SIC: 2834 Pharmaceutical Preparations